Pancreatic cancer is notorious as a cancer that is diagnosed late and is difficult to treat. In fact, it is poised to become the second leading cause of cancer deaths by 2030. Let’s Win Pancreatic Cancer and the National Alliance for Hispanic Health’s Nuestras Voces Network program have teamed up for a webinar to discuss treatment options and the role of clinical trials, with a focus on the need for diverse participants.

The Let’s Learn: Treatments and the Importance of Clinical Trials webinar will be held on Wednesday, November 8th at 2 p.m. Eastern. Oncologist Dr. Allyson J. Ocean and oncologist and entrepreneur Dr. Arturo Loaiza-Bonilla will discuss the different treatment options, and the role of clinical trials in treatments. The moderator is health advocate Daniel G Garza.

Pancreatic cancer is notorious as a cancer that is diagnosed late and is difficult to treat. In fact, it is poised to become the second leading cause of cancer deaths by 2030. About 64,000 people are found to have pancreatic cancer each year in the U.S., with a slightly higher rate of occurrence in Black Americans. The five-year survival rate for pancreatic cancer is about 12 percent, in part because the disease is often diagnosed at an advanced stage.

REGISTER HERE to learn more about pancreatic cancer treatments and clinical trials.

By recruiting diverse patients to clinical trials, researchers gain a better understanding of whether new treatments and protocols work for everyone.